-
1Academic Journal
Συγγραφείς: S. V. Popov, L. N. Maslov, A. V. Mukhomedzyanov, A. S. Slidnevskaya, A. Kan, N. V. Naryzhnaya, Yu. K. Podoksenov, С. В. Попов, Л. Н. Маслов, А. В. Мухомедзянов, А. С. Слидневская, А. Кан, Н. В. Нарыжная, Ю. К. Подоксенов
Συνεισφορές: The study was supported by the Russian Science Foundation grant No. 23-65-10017. The section on ischemic preconditioning and postconditioning was prepared in the framework of the state assignment 122020300042-4, Работа выполнена при финансовой поддержке гранта Российского научного фонда № 23-65-10017. Раздел, посвященный ишемическому прекондиционированию и посткондиционированию, подготовлен в рамках государственного задания 122020300042-4
Πηγή: Siberian Journal of Clinical and Experimental Medicine; Том 39, № 3 (2024); 12-18 ; Сибирский журнал клинической и экспериментальной медицины; Том 39, № 3 (2024); 12-18 ; 2713-265X ; 2713-2927
Θεματικοί όροι: окситоцин, cardioprotective drugs, ischemia/reperfusion, the cardioprotective effect, oxytocin, кардиопротекторные препараты, ишемия/реперфузия, кардиопротекторный эффект
Περιγραφή αρχείου: application/pdf
Relation: https://www.sibjcem.ru/jour/article/view/2419/986; Мотова А.В., Каретникова В.Н., Осокина А.В., Поликутина О.М., Барбараш О.Л. Инфаркт миокарда 2-го типа: особенности диагностики в реальной клинической практике. Сибирский журнал клинической и экспериментальной медицины. 2022;37(3):75–82. DOI:10.29001/2073-8552-2022-37-3-75-82.; Вышлов Е.В., Алексеева Я.В., Усов В.Ю., Мочула О.В., Рябов В.В. Синдром микрососудистого повреждения миокарда у пациентов с первичным инфарктом миокарда с подъемом сегмента ST: распространенность и связь с клиническими характеристиками. Сибирский журнал клинической и экспериментальной медицины. 2022;37(1):36–46. DOI:10.29001/2073-8552-2021-36-4-36-46.; Ashraf S., Farooq U., Shahbaz A., Khalique F., Ashraf M., Akmal R. et al. Factors responsible for worse outcomes in STEMI patients with early vs delayed treatment presenting in a tertiary care center in a Third World Country. Curr. Probl. Cardiol. 2024;49(1 Pt B):102049. DOI:10.1016/j.cpcardiol.2023.102049.; Currey E.M., Falconer N., Isoardi K.Z., Barras M. Impact of pharmacists during in-hospital resuscitation or medical emergency response events: A systematic review. Am. J. Emerg. Med. 2024;75:98–110. DOI:10.1016/j.ajem.2023.10.020.; Hti Lar Seng N.S., Zeratsion G., Pena Zapata O.Y., Tufail M.U., Jim B. Utility of cardiac troponins in patients with chronic kidney disease. Cardiol. Rev. 2024;32(1):62–70. DOI:10.1097/CRD.0000000000000461.; Li M., Hu L., Li L. Research progress of intra-aortic balloon counterpulsation in the treatment of acute myocardial infarction with cardiogenic shock: A review. Medicine (Baltimore). 2023;102(49):e36500. DOI:10.1097/MD.0000000000036500.; Luo Q., Sun W., Li Z., Sun J., Xiao Y., Zhang J. et al. Biomaterials-mediated targeted therapeutics of myocardial ischemia-reperfusion injury. Biomaterials. 2023;303:122368. DOI:10.1016/j.biomaterials.2023.122368.; Nanavaty D., Sinha R., Kaul D., Sanghvi A., Kumar V., Vachhani B. et al. Impact of COVID-19 on Acute myocardial infarction: A national inpatient sample analysis. Curr. Probl. Cardiol. 2024;49(1_Pt_A):102030. DOI:10.1016/j.cpcardiol.2023.102030.; McCartney P.J., Berry C. Redefining successful primary PCI. Eur. Heart J. Cardiovasc. Imaging. 2019;20(2):133–135. DOI:10.1093/ehjci/jey159.; Oliver G., Schäfer E.A. On the physiological action of extracts of pituitary body and certain other glandular organs: Preliminary communication. J. Physiol. 1895;18(3):277–279. DOI:10.1113/jphysiol.1895.sp000565.; Camerino C. The long way of oxytocin from the uterus to the heart in 70 years from its discovery. Int. J. Mol. Sci. 2023;24(3):2556. DOI:10.3390/ijms24032556.; Du Vigneaud V., Ressler C., Trippet S. The sequence of amino acids in oxytocin, with a proposal for the structure of oxytocin. J. Biol. Chem. 1953;205(2):949–957.; Gutkowska J., Jankowski M., Lambert C., Mukaddam-Daher S., Zingg H.H., McCann S.M. Oxytocin releases atrial natriuretic peptide by combining with oxytocin receptors in the heart. Proc. Natl. Acad. Sci. USA. 1997;94(21):11704–11709. DOI:10.1073/pnas.94.21.11704.; Jankowski M., Wang D., Hajjar F., Mukaddam-Daher S., McCann S.M., Gutkowska J. Oxytocin and its receptors are synthesized in the rat vasculature. Proc. Natl. Acad. Sci. USA. 2000;97(11):6207–6211. DOI:10.1073/pnas.110137497.; Thibonnier M., Conarty D.M., Preston J.A., Plesnicher C.L., Dweik R.A., Erzurum S.C. Human vascular endothelial cells express oxytocin receptors. Endocrinology. 1999;140(3):1301–1309. DOI:10.1210/endo.140.3.6546.; Jankowski M., Hajjar F., Kawas S.A., Mukaddam-Daher S., Hoffman G., McCann S.M., Gutkowska J. Rat heart: a site of oxytocin production and action. Proc. Natl. Acad. Sci. USA. 1998;95(24):14558–14563. DOI:10.1073/pnas.95.24.14558.; Wsol A., Kasarello K., Kuch M., Gala K., Cudnoch-Jedrzejewska A. Increased activity of the intracardiac oxytocinergic system in the development of postinfarction heart failure. Biomed. Res. Int. 2016;2016:3652068. DOI:10.1155/2016/3652068.; Ondrejcakova M., Ravingerova T., Bakos J., Pancza D., Jezova D. Oxytocin exerts protective effects on in vitro myocardial injury induced by ischemia and reperfusion. Can. J. Physiol. Pharmacol. 2009;87(2):137– 142. DOI:10.1139/Y08-108.; Kobayashi H., Yasuda S., Bao N., Iwasa M., Kawamura I., Yamada Y. et al. Postinfarct treatment with oxytocin improves cardiac function and remodeling via activating cell-survival signals and angiogenesis. J. Cardiovasc. Pharmacol. 2009;54(6):510–519. DOI:10.1097/FJC.0b013e3181bfac02.; Houshmand F., Faghihi M., Zahediasl S. Biphasic protective effect of oxytocin on cardiac ischemia/reperfusion injury in anaesthetized rats. Peptides. 2009;30(12):2301–2308. DOI:10.1016/j.peptides.2009.09.010.; Authier S., Tanguay J.F., Geoffroy P., Gauvin D., Bichot S., Ybarra N. et al. Cardiovascular effects of oxytocin infusion in a porcine model of myocardial infarct. J. Cardiovasc. Pharmacol. 2010;55(1):74–82. DOI:10.1097/FJC.0b013e3181c5e7d4.; Alizadeh A.M., Faghihi M., Sadeghipour H.R., Mohammadghasemi F., Imani A., Houshmand F. et al. Oxytocin protects rat heart against ischemia-reperfusion injury via pathway involving mitochondrial ATP-dependent potassium channel. Peptides. 2010;31(7):1341–1245. DOI:10.1016/j.peptides.2010.04.012.; Alizadeh A.M., Faghihi M., Sadeghipour H.R., Mohammadghasemi F., Khori V. Role of endogenous oxytocin in cardiac ischemic preconditioning. Regul. Pept. 2011;167(1):86–90. DOI:10.1016/j.regpep.2010.11.004.; Anvari M.A., Imani A., Faghihi M., Karimian S.M., Moghimian M., Khansari M. The administration of oxytocin during early reperfusion, dose-dependently protects the isolated male rat heart against ischemia/reperfusion injury. Eur. J. Pharmacol. 2012;682(1–3):137–141. DOI:10.1016/j.ejphar.2012.02.029.; Das B., Sarkar C. Is preconditioning by oxytocin administration mediated by iNOS and/or mitochondrial K(ATP) channel activation in the in vivo anesthetized rabbit heart? Life Sci. 2012;90(19–20):763–769. DOI:10.1016/j.lfs.2012.03.030.; Alizadeh A.M., Faghihi M., Khori V., Sohanaki H., Pourkhalili K., Mohammadghasemi F. et al. Oxytocin protects cardiomyocytes from apoptosis induced by ischemia-reperfusion in rat heart: role of mitochondrial ATP-dependent potassium channel and permeability transition pore. Peptides. 2012;36(1):71–77. DOI:10.1016/j.peptides.2012.03.023.; Ondrejcakova M., Barancik M., Bartekova M., Ravingerova T., Jezova D. Prolonged oxytocin treatment in rats affects intracellular signaling and induces myocardial protection against infarction. Gen. Physiol. Biophys. 2012;31(3):261–270. DOI:10.4149/gpb_2012_030.; Faghihi M., Alizadeh A.M., Khori V., Latifpour M., Khodayari S. The role of nitric oxide, reactive oxygen species, and protein kinase C in oxytocin-induced cardioprotection in ischemic rat heart. Peptides. 2012;37(2):314–319. DOI:10.1016/j.peptides.2012.08.001.; Wang M., Zhou R., Xiong W., Wang Z., Wang J., He L. et al. Oxytocin mediated cardioprotection is independent of coronary endothelial function in rats. Peptides. 2020;130:170333. DOI:10.1016/j.peptides.2020.170333.; Imani A., Khansari M., Azizi Y., Rakhshan K., Faghihi M. Stimulation of oxytocin receptor during early reperfusion period protects the heart against ischemia/reperfusion injury: the role of mitochondrial ATP-sensitive potassium channel, nitric oxide, and prostaglandins. Acta Med. Iran. 2015;53(8):491–500.; Gonzalez-Reyes A., Menaouar A., Yip D., Danalache B., Plante E., Noiseux N. et al. Molecular mechanisms underlying oxytocin-induced cardiomyocyte protection from simulated ischemia-reperfusion. Mol. Cell. Endocrinol. 2015;412:170–181. DOI:10.1016/j.mce.2015.04.028.; Polshekan M., Jamialahmadi K., Khori V., Alizadeh A.M., Saeidi M., Ghayour-Mobarhan M. et al. RISK pathway is involved in oxytocin postconditioning in isolated rat heart. Peptides. 2016;86:55–62. DOI:10.1016/j.peptides.2016.10.001.; Polshekan M., Khori V., Alizadeh A.M., Ghayour-Mobarhan M., Saeidi M., Jand Y. et al. The SAFE pathway is involved in the postconditioning mechanism of oxytocin in isolated rat heart. Peptides. 2019;111:142– 151. DOI:10.1016/j.peptides.2018.04.002.; Naryzhnaya N.V., Maslov L.N., Popov S.V., Mukhomezyanov A.V., Ryabov V.V., Kurbatov B.K. et al. Pyroptosis is a drug target for prevention of adverse cardiac remodeling: The crosstalk between pyroptosis, apoptosis, and autophagy. J. Biomed. Res. 2022;36(6):375–389. DOI:10.7555/JBR.36.20220123.; Yao M., Wang Z., Jiang L., Wang L., Yang Y., Wang Q., et al Oxytocin ameliorates high glucose- and ischemia/reperfusion-induced myocardial injury by suppressing pyroptosis via AMPK signaling pathway. Biomed. Pharmacother. 2022;153:113498. DOI:10.1016/j.biopha.2022.113498.; de Miranda D.C., de Oliveira Faria G., Hermidorff M.M., Dos Santos Silva F.C., de Assis L.V.M., Isoldi M.C. Pre- and post-conditioning of the heart: An overview of cardioprotective signaling pathways. Curr. Vasc. Pharmacol. 2021;19(5):499–524. DOI:10.2174/1570161119666201120160619.; Houshmand F., Faghihi M., Zahediasl S. Role of atrial natriuretic peptide in oxytocin induced cardioprotection. Heart Lung Circ. 2015;24(1):86– 93. DOI:10.1016/j.hlc.2014.05.023.; Krylatov A.V., Tsibulnikov S.Y., Mukhomedzyanov A.V., Boshchenko A.A., Goldberg V.E., Jaggi A.S. et al. The role of natriuretic peptides in the regulation of cardiac tolerance to ischemia/reperfusion and postinfarction heart remodeling. J. Cardiovasc. Pharmacol. Ther. 2021;26(2):131–148. DOI:10.1177/1074248420952243.; Xiong W., Yao M., Zhou R., Qu Y., Yang Y., Wang Z. et al. Oxytocin ameliorates ischemia/reperfusion-induced injury by inhibiting mast cell degranulation and inflammation in the rat heart. Biomed. Pharmacother. 2020;128:110358. DOI:10.1016/j.biopha.2020.110358.; Stadler B., Whittaker M.R., Exintaris B., Middendorff R. Oxytocin in the Male Reproductive Tract; The Therapeutic Potential of Oxytocin-Agonists and-Antagonists. Front. Endocrinol. (Lausanne). 2020;11:565731. DOI:10.3389/fendo.2020.565731.; https://www.sibjcem.ru/jour/article/view/2419